Putting patient care first with proactive supply chain intelligence

Many pharmaceutical companies depend on a single active pharmaceutical ingredient (API) manufacturer, often located overseas. This creates significant risk if a facility faces regulatory shutdowns, geopolitical disruptions, or raw material shortages.
Resilinc helps companies identify single-source dependencies through multi-tier mapping and part-site visibility. By understanding exactly where APIs and critical materials originate, organizations can evaluate alternative sourcing strategies, diversify supply, and proactively reduce concentration risk before shortages occur.

Biologics and specialty drugs face heightened risk due to complex manufacturing processes, limited production sites, temperature-sensitive handling requirements, and long regulatory approval timelines. Even minor disruptions, such as contamination events, power outages, or packaging shortages, can halt production. Resilinc provides real-time disruption monitoring and deep supplier visibility to help life sciences organizations identify vulnerabilities across sterile manufacturing, cold chain logistics, and specialty materials before patient supply is impacted.

During supply chain disruptions, speed and clarity are critical. However, many organizations rely on fragmented communication and manual outreach to suppliers, slowing response times. Resilinc enables centralized WarRoom collaboration, allowing teams to engage affected suppliers in real time, confirm impact at the part-site level, and execute mitigation workflows quickly. This structured approach reduces uncertainty and accelerates resolution during high-risk events.

Modern forced labor regulations, including UFLPA and the EU Forced Labor Regulation, require traceability beyond Tier 1 suppliers, often down to raw material extraction or sub-component manufacturing. To comply effectively, organizations must validate supplier networks across multiple tiers, assess geographic exposure, and maintain audit-ready documentation. Continuous monitoring of enforcement lists and sanctioned entities is essential to identify hidden exposure and reduce the risk of shipment detentions, import bans, or reputational damage. Resilinc’s UFLPA Agent supports this effort by continuously monitoring CBP and DHS entity list updates, detecting potential supplier exposure, quantifying revenue-at-risk, automating supplier assessments, and tracking remediation workflows. This reduces the likelihood of shipment seizures, import bans, and reputational harm.